Difficulty: Medium
Average Score: 86%
Practice
Recombinant human erythropoietin is used to treat:
Correct answer
C
Rationale
Recombinant human erythropoietin (EPO) treats anemia of chronic renal failure (C), stimulating red blood cell production in kidneys unable to produce endogenous EPO, improving quality of life in dialysis patients. It's not used for iron-deficient anemia (A); iron supplementation is needed. Sickle cell anemia (B) relies on hydroxyurea, not EPO. It treats AZT-related anemia (D) in HIV, countering marrow suppression. It's ineffective in clozapine-induced agranulocytosis (original E). EPO's targeted stimulation of erythropoiesis, monitored via hemoglobin levels, reduces transfusion needs, though hypertension and thrombosis risks require oversight.